Opinion|Videos|August 30, 2024
Strategies to Manage Type 2 Inflammation in Respiratory Diseases
Author(s)Reynold A. Panettieri Jr, MD
A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.
Advertisement
Episodes in this series
- How do these markers influence the treatment regimen for patients with asthma or COPD?
- How do comorbidities affect the management of type 2 inflammation in asthma and COPD?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
2
The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine
3
AI-Supported Mammography Caught More Cancers During Screening
4
Photobiomodulation, Bio-Machines, and the Future of Dermatology
5
